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Objective: An assessment of the effect of otolaryngologi-
cal management on the health-related quality of life of
patients.
Design: Application of the Health Utilities Index mark 3
(HUI-3) before and after treatment; application of the
Glasgow Beneﬁt Inventory (GBI) after treatment.
Setting: Six otolaryngological departments around
Scotland.
Participants: A 9005 adult patients referred to outpatient
clinics.
Main outcome measures: Complete HUI-3 data was col-
lected from 4422 patients; complete GBI data from 4235;
complete HUI-3 and GBI data from 3884.
Results: The overall change in health related quality of
life from before to after management was just +0.02.
In the majority of subgroups of data (classiﬁed by type
of management) there was essentially no change in
HUI-3 score. The major exceptions were those patients
provided with a hearing aid (mean change 0.08) and
those whose problem was managed surgically (mean
change 0.04). The mean GBI score was 5.3 which is
low. Those managed surgically reported a higher GBI
score of 13.0.
Conclusion: We found that patients treated surgically or
given a hearing aid reported a signiﬁcant improvement in
their health related quality of life after treatment in oto-
laryngology departments. In general, patients treated in
other ways reported no signiﬁcant improvement. We
argue that future research should look carefully at patient
groups where there is unexpectedly little beneﬁt from
current treatment methods and consider more effective
methods of management.
Traditionally, outcomes of medical care are based on clini-
cal observations or laboratory measurements, but in recent
years, there has been an increasing recognition that these
need to be complemented by quantitative measures of the
impact of the intervention on patients’ health status or
health-related quality of life (‘HRQoL’). The three major
measures are the Health Utilities Index mark 3 (HUI-3),
1
the EQ-5D,
2 and the SF-36
3 questionnaires. These are gen-
eric questionnaires that are applicable to the full spectrum
of health: their items cover experiences of illness, such as
pain, fatigue, or disability, as well as broader aspects of
the patient’s physical, emotional and social well-being.
The importance of these measures is demonstrated by
their wide use in the current National Services Scotland
(NHS). For instance, the EQ-5D is the questionnaire used
to assess the generic health status in the Patient Reported
Outcome Measures (PROMs) for hip replacements, knee
replacements, hernias and varicose veins.
4 It is also recom-
mended by the National Institute for Health and Clinical
Excellence for the measurement and valuation of HRQoL
in economic evaluations of health care.
5
In audiology and otolaryngology, there have been stud-
ies of HRQoL in the speciﬁc domains of hearing aids
6–8,
cochlear implantation
9–12 and head and neck cancer
13,14.
But there has been no large-scale HRQoL study of the
general population of patients referred to otolaryngology
clinics. We reasoned that such a study would be particu-
larly useful as its outcomes would allow overall compari-
sons of otolaryngology with other specialities, as the
majority of otolaryngology problems are neither life-
threatening nor require surgery and so do not allow com-
parisons by mortality rates or surgical success rates. We
therefore designed a suitable project to address this gap.
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spectrum of patients referred to six otolaryngology clinics
across Scotland and then the changes in HRQoL owing
to their otolaryngological management. We also collected
relevant clinical data. The results are reported according
to patients’ initial diagnosis and how they were managed.
Methods
Ethical considerations
The study was approved by the Scottish Multicentre
Research Ethics Committee. Informed consent was
obtained from all participants. All authors had full access
to all the data.
HRQoL questionnaires
We used two generic instruments, the HUI-3 and the Glas-
gow Beneﬁt Inventory (‘GBI’). We chose the HUI-3
because it has been very widely used in health economic
evaluations across all domains of health care, whereas we
chose the GBI as it has been widely used in otolaryngology.
The HUI-3 is a preference-based utility measure of generic
health status, assessing patient preferences via 12 questions
with four to six available responses for each. From these, an
overall health utility measure is obtained via a weighted
scoring algorithm, giving a single number ranging between
0 (death) and 1 (full health). The algorithm also gives
scores on eight scales of health-status attributes, which also
scale from 0 to 1: Vision, Hearing, Speech, Ambulation,
Dexterity, Emotion, Cognition, and Pain. The HUI-3 is of
relevance to otolaryngology (and indeed also to audiology)
as it includes four questions on hearing and speech under-
standing (note that the EQ-5D does not include such ques-
tions and is mostly insensitive to the effects of impaired
hearing or even from the ‘life-changing’ beneﬁts gained
from a cochlear implant
7,8,15,16). To obtain measures of
beneﬁt from the HUI-3, we applied it both before and after
management and then took the difference.
The GBI was designed to give an assessment of the
patient’s perceived beneﬁt from otolaryngological inter-
ventions
17,18. It has 18 questions that ask directly about
the change in health status resulting from management.
The response to each question is based on a ﬁve-point
Likert scale; these are then scaled and averaged to give a
ﬁnal score ranging between )100 and +100: negative
scores represent a worse outcome, zero no change, and
positive scores represent a beneﬁt. As it was speciﬁcally
designed as a beneﬁt questionnaire, the GBI was applied
once, after management.
Procedure
Figure 1 shows a ﬂowchart of the design. The study was
run between 2001 and 2005, with post-management data
Pre-management HUI-3 posted to patients
in advance of appointment
(Glasgow Royal Infirmary)
Post-management HUI-3 & GBI posted to patients
N = 8043
Lost to follow-up
N = 962
Post-management questionnaires returned
N = 4921
Pre-managementHUI-3 completed: N = 4663
Both HUI-3s fully completed & full clinical data: N = 4422
GBI fullycompleted & full clinical data: N = 4235
All data (HUI-3, GBI, clinical): N = 3884
Not returned
N = 3122
Otolaryngology management
Pre-management HUI-3 given to patients
at appointment
(other clinics)
HUI-3 returned
N = 9005
Three or six months later
Clinical data collected
Patients classified by both
• Primary diagnosis (15 categories)
• Management type (6 types)
Fig. 1. Overall design of the study.
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differed between departments. The aim was to include
adult patients (14 years and older) attending any of six
otolaryngology clinics in Scotland during the study period
(see Table 1). Approximately 62 400 new patients were
seen in these departments during the period of the
study
19, but the actual samples were affected by the work-
load and enthusiasm of the booking clerks and clinic
receptionists and were considerably less than this. The
selection was not inﬂuenced by the authors.
The pre-management HUI-3 was either mailed to the
patient 2 weeks before their appointment with a request
to complete it and return it at their visit (Glasgow Royal
Inﬁrmary) or given to new patients on arrival for their
ﬁrst clinic appointment to be completed before consulta-
tion (other clinics); 9005 were returned (=14% of the
maximum possible sample pool). Either three or
6 months after the completion of management, the post-
management HUI-3 and the GBI were posted to patients.
Three months was appropriate for those who did not
require treatment or were treated medically as they com-
monly had more than one consultation, but as it would
have been too short for recovery from a surgical proce-
dure or for acclimatisation to hearing aids
20,21, we waited
6 months in these groups. 8043 post-management ques-
tionnaires were sent out (the remaining 962 patients were
lost to follow-up: either they defaulted from attendance,
or their clinical data were not returned from the depart-
ment they attended); 4921 were returned, giving a
response rate of 61.2%. This return rate is comparable
with other HRQoL studies where the subjects were asked
by mail to complete the follow-up questionnaire.
Not every questionnaire was fully completed by each
patient as the data were obtained by post, and therefore,
we could not ensure that each question was answered.
4663 patients fully completed the pre-management HUI-3
questionnaire (94.8%), 4422 patients fully completed both
the pre- and post-management HUI-3 questionnaires
(89.8%), and 4235 patients fully completed the GBI
(86.1%). The analyses below concentrate on the N = 4422
and N = 4235 groups. Their mean age was 54 years (stan-
dard deviation = 16 years), and the overall male–female
split was 43)57%. About 80% of the patients were from
either the Glasgow Royal Inﬁrmary or the Aberdeen
Royal Inﬁrmary (see Table 1; for further detail, see Sup-
plementary Table S1). Chi-square tests showed that there
were no signiﬁcant effects in the three contingency tables
of the number of HUI-3 & GBI questionnaires returned
by hospital (v
2 = 2.33, d.f. = 5, P = 0.80), by diagnosis
category (v
2 = 2.48, d.f. = 14, P = 1.00), or by manage-
ment type (v
2 = 0.87, d.f. = 5, P = 0.97).
The patients were classiﬁed into 15 diagnostic catego-
ries on the basis of copies of the letters sent by the clini-
cians to the patient’s family doctor after each visit to the
clinic, which were read and coded by the lead author (see
Table 2). The 15 categories fell into 4 broader classes of
ear related, nose related, throat related, and other. The
patients were also classiﬁed into six types of otolaryngo-
logical management (see Table 3).
Comparison data
We know of no large-scale UK general-population data
for comparing the HUI-3 scores to, so instead we used a
Canadian data set (n = 61536) from the developers of the
HUI-3.
22 From the linear-regression coefﬁcients reported,
there we calculated the expected score for each of our
participants given their sex and age (in decades), and
then these values were used as comparison data. For the
GBI, its deﬁnition as a beneﬁt measure implies that the
baseline value is zero.
Statistical methods
To determine the statistical signiﬁcance of our results, we
used paired-sample Student t-tests (HUI-3), one-sample
Table 1. Overall statistics of the study: reports the age and sex of those who fully completed both pre-and post-management HUI-3
questionnaires
Royal
Inﬁrmary,
Glasgow
Stobhill
Hospital,
Glasgow
Gartnavel
Hospital,
Glasgow
Crosshouse
Hospital,
Kilmarnock
Raigmore
Hospital,
Inverness
Royal
Inﬁrmary,
Aberdeen Total
Number 1575 213 203 305 134 1992 4422
Percentage of total 35.6 4.8 4.6 6.9 3.0 45.0 100
Males : Females (number) 650 : 925 93 : 120 80 : 123 125 : 180 55 : 79 892 : 1100 1895 : 2527
Males : Females (%) 41 : 59 44 : 56 39 : 61 41 : 59 41 : 59 45 : 55 43 : 57
Mean age (years) 56 54 54 57 55 52 54
Standard deviation
of age (years)
16 17 14 16 16 17 16
HUI-3, Health Utilities Index mark 3.
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and chi-square tests (contingency tables), assuming an
alpha of 0.05. Bonferonni corrections were applied to cor-
rect for multiple comparisons in each of the t-tests for
change in HUI-3 score. We did not attempt to modify the
sampling to equate the group sizes across all combinations
Table 2. Main results: the change in Health Utilities Index mark (HUI) from pre-management to post-management and the GBI
score after management. The data are grouped by diagnosis category. The other columns reported the number of people in each
group and other information. Note that not everyone who completed both HUI-3s completed the (GBI), or vice versa, and so the
numbers of people are not necessarily the same. The asterisked results were statistically signiﬁcant after allowing for a 30-test Bonfer-
roni correction
Region Diagnosis Category
Number
(HUI-3)
%
(HUI-3)
Mean age,
years
(HUI-3)
Pre-
management
HUI-3 score
Change
in HUI-3
score
Number
(GBI)
%
(GBI)
Mean
age, years
(GBI)
GBI
score
Ear Sensorineural hearing loss 947 21.3 60 0.566 0.044* 933 22.0 59 2.8*
Ear Inactive middle ear disease 214 4.8 50 0.605 0.072* 215 5.1 49 8.6*
Ear Active middle ear disease 158 3.6 55 0.478 0.084* 154 3.6 54 6.8*
Ear External ear disease 208 4.7 53 0.620 0.056 205 4.8 52 8.9*
Ear Dizziness 410 9.2 55 0.590 0.033 388 9.2 54 3.8*
Ear Neurological problem 93 2.1 57 0.510 )0.026 84 2.0 55 )0.4
Nose Nasal anatomical problem 341 7.8 49 0.723 )0.012 322 7.6 47 8.3*
Nose Rhinosinusitis 573 13.0 51 0.728 0.008 543 12.8 50 6.5*
Nose Snoring 65 1.5 47 0.758 )0.030 62 1.5 48 1.2
Throat Throat Inﬂammation 204 4.6 37 0.752 0.038 205 4.8 36 12.0*
Throat Benign Larynx 143 3.2 59 0.684 )0.017 141 3.3 59 7.2*
Throat Benign Lump 148 3.3 51 0.744 0.004 137 3.2 50 7.3*
Throat Gastro-oesophageal
reﬂux⁄Globus
394 8.9 57 0.688 )0.029 353 8.3 55 3.7*
Other Malignancy 34 0.8 66 0.686 )0.121 31 7.3 64 7.0
Other No abnormality detected
(NAD)
490 11.1 53 0.711 0.026 462 10.9 63 3.3
Total 4422 100 54 0.650 0.021 4235 100 53 5.3
GBI, Glasgow Beneﬁt Inventory; HUI-3, Health Utilities Index mark 3.
Table 3. As Table 2, but grouped by management type. The asterisked results were statistically signiﬁcant after allowing for a 12-test
Bonferroni correction
Classiﬁcation Deﬁnition
Number
(HUI-3)
%
(HUI-3)
Mean age,
years
(HUI-3)
Pre-
management
HUI-3 score
Change
in HUI-3
score
Number
(GBI)
%
(GBI)
Mean
age, year
(GBI)
GBI
score
‘Reassure’ = given reassurance
or advice on
self-management
1756 39.7 54 0.694 0.008 1700 40.0 53 1.7*
‘Medical
treatment’
= topical or systemic
medication
1055 23.9 55 0.665 0.004 978 23.0 53 5.2*
‘Therapy’ = speech therapy,
vestibular exercises,
or physiotherapy
222 5.0 64 0.584 0.017 511 12.1 63 6.6*
‘Hearing aid
provision’
= hearing aid
provided or
replaced
534 12.1 58 0.452 0.084* 210 5.0 57 7.0*
‘Surgery’ = managed surgically 781 17.7 46 0.694 0.038* 762 18.0 45 13.0*
‘Refer on’ = referred to another
specialist
74 1.7 52 0.580 )0.008 74 1.7 51 )1.8
Total 4422 100 54 0.650 0.021 4235 100 53 5.3
GBI, Glasgow Beneﬁt Inventory; HUI-3, Health Utilities Index mark 3.
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relatively uncommon. Accordingly, in the text, we concen-
trate on those combinations with at least 20 people, chosen
arbitrarily, although all the results are reported in the sup-
plementary tables. All statistical calculations were carried
out in PASW (SPSS) version 18 or Excel 2007.
Results
Health utilities index
Across the group of 4422 patients who fully completed
both HUI-3 questionnaires, the mean pre-management
HUI-3 score was 0.650 (SD = 0.307). The mean value for
the comparison population was 0.83, so indicating that
the overall HRQoL of the present sample was substan-
tially poorer.
We found that the pre-management HUI-3 scores dif-
fered substantially across the 15 diagnostic categories, from
0.478 to 0.758 (see Table 2). There was a substantial varia-
tion in mean age across category, ranging from 37 years
(throat inﬂammation) to 66 years (malignancy). There was
a small overall correlation between age and pre-manage-
ment HUI-3 score: the older the patient, the lower their
reported score (r = )0.21, d.f. = 4621, P < 0.001),
although it was much less than the corresponding correla-
tion in the control group (r = )0.76, d.f. = 4921, P <
0.001). The pre-management HUI-3 scores also differed
substantially across management type, from 0.452 for those
provided with a hearing aid to 0.694 for both those reas-
sured or managed surgically (see Supplementary Table S2).
The mean change in HUI-3 score from before to after
(termed ‘D’) across all 4422 patients was +0.021 (stan-
dard deviation = 0.23). This was statistically signiﬁcantly
different from zero (t = 6.13, d.f. = 4421), although
unsurprisingly so given the very large number of patients.
The largest positive change in HUI-3 was found for the
diagnosis category of active middle ear disease
(D = 0.084); the largest negative change was for the
malignancy category (D = )0.121). The change in HUI-3
was statistically signiﬁcant for just three of the 15 diagno-
sis categories, all related to the ear: sensorineural hearing
loss, active middle ear disease and inactive middle ear
disease (see Table 2). It was also statistically signiﬁcant
for two management types (see Table 3), hearing aid pro-
vision and surgery (D = 0.084 and 0.038, respectively),
but not for the four others. Of the 90 combinations of
management type by diagnosis, only two gave a statisti-
cally signiﬁcant change in HUI-3: hearing aid provi-
sion⁄sensorineural hearing loss (D = 0.08) and
surgery⁄active middle ear disease (D = 0.16). Although
some of the other combinations gave large changes, none
were statistically signiﬁcant after a Bonferroni correction
for multiple comparisons was applied (see Supplementary
Table S2). Table 4 summarises those combinations of
management⁄diagnosis that gave a D of at least ±0.05
23
and were based on at least 20 people. It is noteworthy
that four of the ﬁve ear-related diagnosis categories
appear at least once on the list for D > +0.05 – the
exception is neurological problems, which instead is on
the < )0.05 list – whereas none of the 11 diagnosis cate-
gories related to the nose, throat, or other appear on the
> +0.05 list; though, three do on the < )0.05 list. It is
perhaps to be expected that there was a substantial reduc-
tion in quality of life for surgery for malignancy of the
head and neck (D = )0.159).
Table 4. The combinations of management type⁄diagnosis category that gave the largest absolute changes in HUI-3 score, based on
at least 20 people. The groups are sorted by the size of the change
Management type Diagnosis category Number
Pre-management
HUI-3 score
Change in
HUI-3 score
Gain or reduction
in HUI-3 score?
Surgery Active middle ear disease 62 0.478 +0.156 Gain
Surgery Inactive middle ear disease 55 0.608 +0.139 Gain
Medical treatment Dizziness 41 0.564 +0.099 Gain
Hearing aid provision Inactive middle ear disease: 53 0.476 +0.085 Gain
Therapy SNHL 42 0.494 +0.077 Gain
Hearing aid provision SNHL 437 0.459 +0.084 Gain
Medical treatment External ear disease: 143 0.630 +0.055 Gain
Reassure External ear disease 45 0.680 +0.054 Gain
Reassure Snoring 38 0.790 )0.051 Reduction
Medical treatment Nasal anatomical problem 138 0.688 )0.054 Reduction
Refer on Neurological problem 21 0.540 )0.055 Reduction
Surgery Malignancy 26 0.724 )0.159 Reduction
HUI-3, Health Utilities Index mark 3.
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management type gave a change as large as ±0.05: hearing
subscale⁄hearing aid provision (Supplementary Table S3).
Three combinations gave a statistically signiﬁcant change:
hearing subscale⁄hearing aid provision; speech sub-
scale⁄hearing aid provision; and pain subscale⁄surgery.
Each of these would be expected.
Glasgow beneﬁt inventory
4235 completed GBI questionnaires were returned. The
mean score in the GBI was 5.32 (standard devia-
tion = 17.3). This value was remarkably low given that
the GBI scale is from )100 to +100, although it was sta-
tistically signiﬁcantly different from 0 (t = 20.1,
d.f. = 4234). When the values are divided by 100 to place
them on the same scale as the change in HUI-3, which
can range from )1 to +1, then the GBI score corresponds
to 0.05, which is of the same order of magnitude as the
overall changes in HUI-3 scores reported earlier.
When classiﬁed by diagnosis category (Table 2), the
largest GBI scores were found for throat inﬂammation
(12.0), external ear disease (8.9), and inactive middle ear
disease (8.6; see Table 2). The scores for all but three
diagnosis categories were signiﬁcantly different from zero:
the exceptions were neurological problems, snoring and
malignancy. Of the six types of management (Table 3),
surgery gave the highest mean GBI score (13.0). The
other types gave GBI scores between 5 and 6 (hearing aid
provision, medical treatment and therapy) or between )2
and + 2 (reassurance, refer on). All but refer on were sig-
niﬁcantly different from zero.
In contrast to the HUI-3 data, numerous combinations
of diagnosis category and management type – including
six of the 15 combinations with surgery – gave a signiﬁ-
cant effect after applying a Bonferroni correction for mul-
tiple comparisons (Supplementary Table S4).
Health utilities index mark 3 versus Glasgow beneﬁt
inventory
3879 patients fully completed both HUI-3 questionnaires
and the GBI questionnaire, representing 88% of those
who completed both HUI-3s. The overall correlation
between the change in HUI-3 and the GBI score was only
+0.20, although given the very large sample size, this was
statistically signiﬁcant. When divided by management
type, the largest correlation was for surgery (r = 0.270)
and the lowest for reassurance (r = 0.164). When divided
by diagnosis category, the correlations were between 0.1
and 0.3, excepting snoring (r = 0.478) and benign lump
(r = 0.060). A comparison of the data in the Supplemen-
tary Tables indicates that the differences within diagnostic
category by management type were more likely to be sta-
tistically signiﬁcant with the GBI than with the change in
HUI-3.
Discussion
Synopsis of key ﬁndings
This is the ﬁrst major large-scale study of the health-
related quality of life (HRQoL) of patients referred to
otolaryngology clinics. Over 4400 patients completed both
HUI-3 questionnaires. We believe the general distribution
of symptoms and diagnoses to be reasonably typical of
otolaryngological referrals across the UK.
With some notable exceptions discussed later, the over-
all change in HRQoL owing to otolaryngological manage-
ment was disappointingly small. The mean increase in
HUI-3 score from pre-management to post-management
was only 0.021, on a scale from 0 to 1; the beneﬁt mea-
sured using the GBI was only 5.3, on a scale from )100
to + 100.
We classiﬁed the otolaryngological intervention into 6
overall types. Both surgical management and hearing aid
provision groups gave statistically signiﬁcant increases in
HRQoL of, respectively, 0.084 and 0.038, whereas the
other four types gave insigniﬁcant changes of therapy
(0.017), reassurance (0.008), medical treatment (0.004),
and refer on ()0.008). The size of the effects in some of
the groups is broadly comparable with that observed in
prior studies: for instance, we observed a mean change of
0.084 for the 437 patients with SNHL treated by a hear-
ing aid, whereas Grutters et al.
7 reported a mean change
of 0.12 in the HUI-3 in patients after hearing aid ﬁtting.
These results are all encouraging and clearly demon-
strate that some – although only some –otolaryngological
interventions can lead to measurable increases in quality
of life when measured using a generic instrument.
Does one always expect an improvement in HRQoL?
When the patients were subdivided by diagnosis category,
the results showed that only some diagnoses and manage-
ment types gave increases in HRQoL. We found that
there was a statistically signiﬁcant increase in HRQoL for
just two subdivisions: sensorineural hearing loss treated
by hearing aid provision and those with active middle ear
disease treated surgically. Although part of this effect may
be a small sample size in some subdivisions (further dis-
cussed later), it is clear that many combinations of diag-
nosis and management type led to only minimal effects
on HRQoL.
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23. For only the surgery and hear-
ing aid groups were there substantially more patients –
around 20% – with a change >0.05 than with < )0.05
(Table S5). Across all 4422 patients, there were only 8%
more patients with a change >0.05 than with < )0.05. It
is clear that only a fraction of the patients seen in otolar-
yngology clinics report a beneﬁt in HRQoL.
Undoubtedly, there are many patients referred to oto-
laryngology where no improvement in HRQoL is to be
expected, as they are referred for a diagnosis rather than
the expectation of successful management. One example
is patients with a feeling of a lump in the throat. Their
referral is principally to exclude malignancy, and these
patients are unlikely to have any detrimental impact on
their HRQoL from their condition, other than concern
about possible diagnoses, and the treatment is unlikely to
change it. Our results bore out this expectation: the mean
increase in HUI-3 score for those whose primary symp-
tom was benign lump was 0.004 (N = 148). We argue
that these results indicate the limitations of a generic
instrument: that the corresponding GBI score was 7.6
(N = 126) indicates that there are aspects to health that
are not captured by the HUI-3. There are other groups of
patients for whom management has been shown to be
effective by use of disease-speciﬁc questionnaires, for
example the SNOT questionnaire applied to rhinosinus-
itis
24. In our sample, this particular group reported no
signiﬁcant improvement in either HUI-3 (0.008) or the
GBI score (6.5). Disease-speciﬁc questionnaires are more
likely to detect changes that occur in that particular con-
dition, but they do not allow comparison with treatment
for other conditions.
For many other conditions, there is no effective cure,
for example tinnitus or mild unilateral hearing impair-
ment, and here, the aim of otolaryngological management
is to offer reassurance and advice. In other cases, the
management is to encourage patients to make changes to
their lifestyle: for example for those with laryngitis to stop
smoking or those who snore to lose weight. These groups
are unlikely to think that their HRQoL has improved in
the short term, although it is hoped that, in some at least,
their health will improve in the long term if they make
the recommended lifestyle changes. It is of interest that
for those diagnosed with dizziness, the mean change in
HRQoL was small (0.033), but the range of scores was
wide: some patients noticed a large improvement in
HRQoL, while others felt that their situation had become
worse. This is a large patient group with a poor HRQoL
who are often not well managed. We note that the prob-
lem has been recognised nationally, and the efforts are
being made to improve management.
Strengths and weaknesses
The primary strength of this study is its large-scale, com-
prehensive design, deliberately covering all aspects of
ENT and including patients from across Scotland. The
results quantify HRQoL across the whole discipline of
ENT, and the concomitant proportions of diagnoses seen
and otolaryngological managements used may encourage
future clinical audits.
There are some potential weaknesses, however. First,
although over 4000 people completed the question-
naires, around 62000 people attended all six participat-
ing ENT clinics during the period of the project. We
therefore only sampled a small proportion of the eligi-
ble population. The initial distribution of questionnaires
was made by the clinics’ booking clerks and clinic
receptionists and undoubtedly ﬂuctuated across clinic
and time. We did not inﬂuence their work in anyway.
We therefore argue that the sample is effectively ran-
dom, and regard it as unlikely that there was any sub-
stantial systematic bias for or against any group of
patients which could have affected the results (although
we note that malignancy may be under-represented, as
such patients are often seen urgently and thus would
have bypassed the project, and their treatment is often
prolonged such that they would not have been asked to
complete post-management questionnaires). A corollary
is that we could not vary the sampling to ensure that
all groups would be equally sized, as some diagnoses
were somewhat rare; for instance, only 65 participants
had a diagnosis of snoring. The result is a reduction in
statistical power of some comparisons, but we felt that
this was outweighed by the pragmatic disadvantage of
continuing sampling, perhaps for many years, until all
groups were equally sized. We also note that our classi-
ﬁcation of management types was, by necessity, some-
what broad, and for simplicity, we stipulated that each
particular intervention could only fall into one overall
type. In some circumstances, this could be questioned:
for instance, one can argue that surgery for the diagno-
sis of lumps could also be classiﬁed as reassurance,a s
in most cases, the clinical result is that the lump was
indeed benign. The full data presented in the Supple-
mentary Tables will help if such details are of interest,
and we hope that the results will suggest targeted fol-
low-up work looking at speciﬁc categories of diagnosis
or management.
Second, about 30% of those who were sent the post-
management questionnaires did not return them. There
were no substantial variations in this across the six clinics
(Table 1). Analysis showed that there was a similar distri-
bution of patients across clinic and diagnostic category
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those who did. There was only a minimal difference in
the mean pre-management HUI-3 score (0.66 versus.
0.65), but the age of those who returned the question-
naires was substantially older (54 versus. 46 years). It is
not obvious why the return rate was higher in older
patients; perhaps, they had more time available to com-
plete the questionnaires.
Third, we found that the overall HRQoL of the
patients was poorer in comparison with an age- and
sex-matched normal Canadian population
22, the values
being 0.65 versus. 0.83. This is a surprisingly large differ-
ence on which future studies may be warranted. It may
be related to the likelihood that many otolaryngological
patients often have other unrelated medical problems
and are on several different medications unrelated to
their otolaryngological condition. Many conditions com-
mon in the elderly can have a large effect on HRQoL:
the cited Canadian data showed an overall reduction of
0.16 from reference for patients with arthritis and 0.39
for those who had a stroke. But there may also be an
overall factor of general health, as it is known that the
general health of the population in Scotland is poor in
comparison with other countries and, indeed, varies
considerably within Scotland: we note that the mean
HRQoL for the patients attending the Glasgow Royal
Inﬁrmary was only 0.57, whereas the values for the
other hospital were 0.63 (Crosshouse), 0.67 (Stobhill)
and 0.70 (Gartnavel, Raigmore and Aberdeen Royal
Inﬁrmary).
Conclusion
We measured the health-related quality of life using the
HUI-3 of 4422 patients referred to six otolaryngology
clinics across Scotland. Patients were classiﬁed according
to their diagnosis and how they were managed. We found
that some groups gave a statistically signiﬁcant improve-
ment in their health-related quality of life after treatment
in otolaryngology departments but many did not. 4235
patients also completed the GBI questionnaire. Its results
were loosely related to the HUI-3 results, although there
were more groups that gave a signiﬁcant beneﬁt. The
largest changes in HUI-3 were seen in patients provided
with a hearing aid (mean change 0.084) and those man-
aged surgically (mean change, 0.038); the largest GBI
scores were seen in those managed surgically (13.2), by
therapy (7.0), and provided with a hearing aid (6.6.). We
argue that future research should look carefully at patient
groups where there is little beneﬁt from current treatment
methods and consider more effective methods of manage-
ment.
Keypoints
• Only a small proportion of patients referred to
otolaryngology in Scotland have a signiﬁcant
improvement in their health-related quality of life
(HUI-3).
• Those patients provided with a hearing aid or
managed surgically reported a statistically signiﬁcant
overall improvement in their health-related quality of
life (HUI-3).
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Additional Supporting Information may be found in the
online version of this article.
Table S1. The number of questionnaires returned at each
stage of the study for each of the hospitals participating
Table S2. Values of pre-management Health Utilities
Index mark 3 (HUI-3) score and the pre- to post-change
in HUI-3 score for the 4422 people who fully completed
both pre- and post-management HUI-3 questionnaires
for every combination of diagnostic category (rows) and
management type (columns). The asterisked differences
were statistically signiﬁcant after allowing for a 36-test
Bonferroni correction. ‘D’ refers to the mean change in
HUI-3 from before to after
Table S3. Values of the pre- to post-change in Health
Utilities Index mark 3 (HUI-3) score for each subscale of
the HUI-3. The data are for the 4422 people who fully
completed both pre- and post-management HUI-3 ques-
tionnaires. The asterisked results were statistically signiﬁ-
cant after allowing for a 27-test Bonferroni correction
Table S4. As Table S1 but for the values of the post-
management Glasgow Beneﬁt Inventory (GBI). The data
are for the 4235 people who fully completed it
Table S5. The numbers of patients whose change in
Health Utilities Index mark 3 (HUI-3) score was larger
than 0.05, <0.05, or in-between, expressed as proportions.
The management types are sorted in order of the positive
vs. negative difference. The ‘random data’ row reports what
would be expected given no change at all. It was calculated
using a numerical simulation of normally distributed data
with a standard deviation of 0.3 (about that of the our
data) and with a test-retest correlation of 0.75 (about that
of the HUI-3; for example, Jones et al. 2005
25)
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